PNEUBEVAX 14

Overview: Pneubevax 14, produced by Biological E. Limited (BE), is a Pneumococcal Polysaccharide Conjugate Vaccine designed to protect against 14 serotypes of Streptococcus pneumoniae. It helps prevent pneumonia, meningitis, sepsis, and acute otitis media in infants. How It Works: This vaccine contains polysaccharides from the bacterial capsule, which help stimulate the immune system to develop protection against pneumococcal infections.

• ✓PCV14 by Biological E protecting against 14 serotypes of Streptococcus pneumoniae
• ✓Broader serotype coverage than standard PCV10 and PCV13 vaccines
• ✓Prevents pneumonia, meningitis, sepsis, and acute otitis media in infants
• ✓Conjugated formulation for strong immune response in infants from 6 weeks of age

Requires 4 doses